Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders
US8153121B2 · kind B2 · utility
9Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2002 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Jul 30, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of reducing the severity of an autoimmune condition associated with T-lymphocyte infiltration. The invention also provides a method of diagnosing or predicting the susceptibility to an autoimmune disease associated with fibroblast mediated T-lymphocyte infiltration. Methods of identifying a substance capable of modulating T-lymphocyte recruitment associated with an autoimmune condition also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.